BioCryst Pharmaceuticals, Inc. - stock earnings
BCRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -61.7 million USD | 93.4 million USD |
| 2023Q3 | -36.1 million USD | 86.7 million USD |
| 2023Q2 | -75.3 million USD | 82.5 million USD |
| 2023Q1 | -53.3 million USD | 68.8 million USD |
| 2022Q4 | -71.5 million USD | 79.5 million USD |
| 2022Q3 | -42.5 million USD | 75.8 million USD |
| 2022Q2 | -58.9 million USD | 65.5 million USD |
| 2022Q1 | -74.2 million USD | 49.9 million USD |
| 2021Q4 | -17.8 million USD | 47.2 million USD |
| 2021Q3 | -58.8 million USD | 41.0 million USD |
| 2021Q2 | -43.2 million USD | 50.0 million USD |
| 2021Q1 | -64.3 million USD | 19.1 million USD |
| 2020Q4 | -60.5 million USD | 4.0 million USD |
| 2020Q3 | -46.1 million USD | 6.1 million USD |
| 2020Q2 | -38.6 million USD | 2.9 million USD |
| 2020Q1 | -37.6 million USD | 4.8 million USD |
| 2019Q4 | -2.6 million USD | 39.7 million USD |
| 2019Q3 | -37.6 million USD | 1.8 million USD |
| 2019Q2 | -37.6 million USD | 1.4 million USD |
| 2019Q1 | -31.1 million USD | 5.9 million USD |
| 2018Q4 | -27.4 million USD | 2.7 million USD |
| 2018Q3 | -29.6 million USD | 1.5 million USD |
| 2018Q2 | -18.4 million USD | 12.5 million USD |
| 2018Q1 | -25.8 million USD | 4.0 million USD |
| 2017Q4 | -19.5 million USD | 3.9 million USD |
| 2017Q3 | -15.1 million USD | 8.8 million USD |
| 2017Q2 | -16.9 million USD | 3.1 million USD |
| 2017Q1 | -14.2 million USD | 9.4 million USD |
| 2016Q4 | -4.5 million USD | 9.0 million USD |
| 2016Q3 | -11.5 million USD | 7.8 million USD |
| 2016Q2 | -16.3 million USD | 4.8 million USD |
| 2016Q1 | -22.8 million USD | 4.8 million USD |
| 2015Q4 | -18.1 million USD | 4.6 million USD |
| 2015Q3 | -14.6 million USD | 11.0 million USD |
| 2015Q2 | 4.9 million USD | 25.8 million USD |
| 2015Q1 | -15.2 million USD | 6.8 million USD |
| 2014Q4 | -11.7 million USD | 5.4 million USD |
| 2014Q3 | -8.7 million USD | 3.2 million USD |
| 2014Q2 | -14.6 million USD | 1.5 million USD |
| 2014Q1 | -10.1 million USD | 3.5 million USD |
| 2013Q4 | -5.4 million USD | 10.6 million USD |
| 2013Q3 | -8.0 million USD | 2.4 million USD |
| 2013Q2 | -12.2 million USD | 821000 USD |
| 2013Q1 | -4.5 million USD | 3.6 million USD |
| 2012Q4 | -11.1 million USD | 4.1 million USD |
| 2012Q3 | -9.7 million USD | 5.8 million USD |
| 2012Q2 | -12.3 million USD | 4.2 million USD |
| 2012Q1 | -6.1 million USD | 12.2 million USD |
| 2011Q4 | -13.2 million USD | 5.2 million USD |
| 2011Q3 | -14.5 million USD | 5.2 million USD |
| 2011Q2 | -16.3 million USD | 3.7 million USD |
| 2011Q1 | -13.0 million USD | 5.4 million USD |
| 2010Q4 | -10.2 million USD | 16.7 million USD |
| 2010Q3 | -10.9 million USD | 12.0 million USD |
| 2010Q2 | -10.2 million USD | 7.6 million USD |
| 2010Q1 | -2.6 million USD | 26.1 million USD |
| 2009Q4 | 15.2 million USD | 54.9 million USD |
| 2009Q3 | -10.6 million USD | 10.5 million USD |
| 2009Q2 | -8.7 million USD | 4.8 million USD |
| 2009Q1 | -9.3 million USD | 4.4 million USD |
| 2008Q4 | 10.1 million USD | 34.2 million USD |
| 2008Q3 | -9.0 million USD | 8.9 million USD |
| 2008Q2 | -12.7 million USD | 2.7 million USD |
| 2008Q1 | -13.1 million USD | 10.8 million USD |
| 2007Q4 | -2.3 million USD | 28.2 million USD |
| 2007Q3 | -11.0 million USD | 20.5 million USD |
| 2007Q2 | -7.0 million USD | 13.4 million USD |
| 2007Q1 | -8.8 million USD | 9.2 million USD |
| 2006Q4 | -10.0 million USD | 2.1 million USD |
| 2006Q3 | -15.6 million USD | 1.8 million USD |
| 2006Q2 | -10.1 million USD | 1.6 million USD |
| 2006Q1 | -7.9 million USD | 771000 USD |
| 2005Q4 | -7.2 million USD | 20867 USD |
| 2005Q3 | -7.6 million USD | 32000 USD |
| 2005Q2 | -5.6 million USD | 58000 USD |
| 2005Q1 | -5.6 million USD | 41000 USD |
| 2004Q4 | -5.3 million USD | -331099 USD |
| 2004Q3 | -5.3 million USD | 270000 USD |
| 2004Q2 | -5.1 million USD | 217000 USD |
| 2004Q1 | -5.5 million USD | 181000 USD |
| 2003Q4 | -3.3 million USD | 838000 USD |
| 2003Q3 | -3.4 million USD | 222000 USD |
| 2003Q2 | -3.3 million USD | 266000 USD |
| 2003Q1 | -2.8 million USD | 308000 USD |
| 2002Q4 | -2.7 million USD | 362524 USD |
| 2002Q3 | -3.4 million USD | 412000 USD |
| 2002Q2 | -5.2 million USD | 461000 USD |
| 2002Q1 | -5.6 million USD | 539000 USD |
| 2001Q4 | -5.0 million USD | 3.4 million USD |
| 2001Q3 | 417000 USD | 3.4 million USD |
| 2001Q2 | 958000 USD | 3.6 million USD |
| 2001Q1 | -1.4 million USD | 703000 USD |
| 2000Q4 | -9.8 million USD | -1.4 million USD |
| 2000Q3 | -1.6 million USD | 60000 USD |
| 2000Q2 | -2.0 million USD | 482000 USD |
| 2000Q1 | 1.9 million USD | 5.2 million USD |
| 1999Q4 | -400000 USD | ? USD |
| 1999Q3 | -2.2 million USD | 100000 USD |
| 1999Q2 | -300000 USD | 2.2 million USD |
| 1999Q1 | -2.4 million USD | 200000 USD |
| 1998Q4 | -1.5 million USD | 400000 USD |
| 1998Q3 | 2.7 million USD | 6.0 million USD |
| 1998Q2 | -3.0 million USD | 100000 USD |
| 1998Q1 | -3.0 million USD | 100000 USD |
| 1997Q4 | -2.9 million USD | ? USD |
| 1997Q3 | -2.5 million USD | 100000 USD |
| 1997Q2 | -2.1 million USD | 1.4 million USD |
| 1997Q1 | -3.1 million USD | 500000 USD |
| 1996Q4 | -2.1 million USD | 500000 USD |
| 1996Q3 | -2.5 million USD | 300000 USD |
| 1996Q2 | -2.2 million USD | 100000 USD |
| 1996Q1 | -1.9 million USD | 100000 USD |
| 1995Q4 | -2.2 million USD | 100000 USD |
| 1995Q3 | -1.9 million USD | 100000 USD |
| 1995Q2 | -1.6 million USD | 100000 USD |
| 1995Q1 | -2.9 million USD | 200000 USD |
| 1994Q4 | -1.8 million USD | 200000 USD |
| 1994Q3 | -1.6 million USD | 200000 USD |
| 1994Q2 | -1.9 million USD | 100000 USD |
| 1994Q1 | -1.6 million USD | 100000 USD |
BCRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -226.5 million USD | 331.4 million USD |
| 2022 | -247.1 million USD | 270.8 million USD |
| 2021 | -184.1 million USD | 157.2 million USD |
| 2020 | -196.6 million USD | 17.8 million USD |
| 2019 | -120.1 million USD | 48.8 million USD |
| 2018 | -101.3 million USD | 20.7 million USD |
| 2017 | -65.8 million USD | 25.2 million USD |
| 2016 | -55.1 million USD | 26.4 million USD |
| 2015 | -43.0 million USD | 48.3 million USD |
| 2014 | -45.2 million USD | 13.6 million USD |
| 2013 | -30.1 million USD | 17.3 million USD |
| 2012 | -39.1 million USD | 26.3 million USD |
| 2011 | -56.9 million USD | 19.6 million USD |
| 2010 | -32.7 million USD | 63.5 million USD |
| 2009 | -13.5 million USD | 74.6 million USD |
| 2008 | -24.7 million USD | 56.6 million USD |
| 2007 | -29.1 million USD | 71.2 million USD |
| 2006 | -43.6 million USD | 6.2 million USD |
| 2005 | -26.1 million USD | 151867 USD |
| 2004 | -21.1 million USD | 336901 USD |
| 2003 | -12.7 million USD | 1.6 million USD |
| 2002 | -16.9 million USD | 1.8 million USD |
| 2001 | -5.0 million USD | 11.2 million USD |
| 2000 | -11.6 million USD | 3.3 million USD |
| 1999 | -5.3 million USD | 2.5 million USD |
| 1998 | -4.8 million USD | 6.4 million USD |
| 1997 | -10.6 million USD | 1.0 million USD |
| 1996 | -8.6 million USD | 200000 USD |
| 1995 | -8.6 million USD | 200000 USD |
| 1994 | -6.9 million USD | 700000 USD |
BCRX
Price: $4.16
52 week price:
Earnings Per Share: -1.18 USD
P/E Ratio: -4.06
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -12.8 millionMarket Capitalization: 948.3 million